PL3423076T3

Topical cyclosporine-containing formulations and uses thereof

Abstract

This record has no abstract on file.

Term

10.4 yearsto projected expiry

Projected expiry 28 February 2037, counted from filing; an application has no term until it is granted.

  1. Priority and filed
  2. Published
  3. Today
  4. Projected expiry

51 members in 21 offices

This recordMember, by publication date11 more offices are in the list below

Members51

Family members, oldest first
DocumentOfficeKind
ZA201904704A0South AfricaA0
CA3015626A1CanadaA1
WO2017151657A1World Intellectual Property Organization (WIPO)A1
AU2017227585A1AustraliaA1
KR20180117661ARepublic of KoreaA
MX2018010395AMexicoA
EP3423076A1European Patent Office (EPO)A1
BR112018067946A2BrazilA2
US2019060397A1United States of AmericaA1
JP2019507154AJapanA
CN109843316AChinaA
SG11201906729RASingaporeA
IL268056AIsraelA
IL268056D0IsraelD0
EP3423076A4European Patent Office (EPO)A4
US10918694B2United States of AmericaB2
RU2019130403ARussian FederationA
RU2019130403A3Russian FederationA3
RU2747455C2Russian FederationC2
US2021145924A1United States of AmericaA1
SA519410114ASaudi ArabiaA
AU2017227585B2AustraliaB2
JP7072517B2JapanB2
AU2017227585C1AustraliaC1
AU2022203135A1AustraliaA1
JP2022110054AJapanA
ZA201904704ASouth AfricaA
ZA201904704BSouth AfricaB
BR112018067946A8BrazilA8
US2023083458A1United States of AmericaA1
NZ755442ANew ZealandA
SA14995B1Saudi ArabiaB1
SA519410114B1Saudi ArabiaB1
US11951153B2United States of AmericaB2
EP3423076B1European Patent Office (EPO)B1
US2024197818A1United States of AmericaA1
FI3423076T3FinlandT3
PT3423076TPortugalT
DK3423076T3DenmarkT3
EP4410312A2European Patent Office (EPO)A2
PL3423076T3This recordPolandT3
JP7547411B2JapanB2
MX2024010721AMexicoA
MX2024010721AMexicoA
ES2981702T3SpainT3
JP2024161602AJapanA
EP4410312A3European Patent Office (EPO)A3
CN119185511AChinaA
KR102766771B1Republic of KoreaB1
NZ785158ANew ZealandA
AU2022203135B2AustraliaB2